Literature DB >> 32715758

Systemic inhibition of miR-451 increases fibrotic signaling and diminishes autophagic response to exacerbate renal damage in Tallyho/Jng mice.

Maurice B Fluitt1, Narayan Shivapurkar1, Manju Kumari2, Sarojini Singh2, Lijun Li1, Swasti Tiwari2, Carolyn M Ecelbarger1.   

Abstract

miRNAs provide fine tuning of gene expression via inhibition of translation. miR-451 has a modulatory role in cell cycling via downregulation of mechanistic target of rapamycin. We aimed to test whether chronic systemic inhibition of miR-451 would enhance renal fibrosis (associated with deranged autophagy). Adult TallyHo/Jng mice (obese insulin resistant) were randomized to two treatment groups to receive either miR-451 inhibition [via a locked nucleic acid construct] or a similar scrambled locked nucleic acid control for 8 wk. All mice were fed a high-fat diet (60% kcal from fat) ad libitum and humanely euthanized after 12 wk. Kidneys and blood were collected for analysis. Renal expression of miR-451 was sixfold lower in inhibitor-treated mice compared with control mice. miR-451 inhibition increased kidney weight and collagen and glycogen deposition. Blood chemistry revealed significantly higher Na+ and anion gap (relative metabolic acidosis) in inhibitor-treated mice. Western blot analysis and immunohistochemistry of the kidney revealed that the inhibitor increased markers of renal injury and fibrosis, e.g., kidney injury molecule 1, neutrophil gelatinase-associated lipocalin, transforming growth factor-β, 14-3-3 protein-ζ, mechanistic target of rapamycin, AMP-activated protein kinase-α, calcium-binding protein 39, matrix metallopeptidase-9, and the autophagy receptor sequestosome 1. In contrast, the inhibitor reduced the epithelial cell integrity marker collagen type IV and the autophagy markers microtubule-associated protein 1A/1B light chain 3B and beclin-1. Taken together, these results support a protective role for miR-451 in reducing renal fibrosis by enhancing autophagy in obese mice.

Entities:  

Keywords:  autophagy; diabetes; diabetic nephropathy; microRNAs

Mesh:

Substances:

Year:  2020        PMID: 32715758      PMCID: PMC7509278          DOI: 10.1152/ajprenal.00594.2019

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  55 in total

1.  MicroRNA-29 enhances autophagy and cleanses exogenous mutant αB-crystallin in retinal pigment epithelial cells.

Authors:  Jingjing Cai; He Zhang; Yun-Feng Zhang; Zhonglou Zhou; Shengzhou Wu
Journal:  Exp Cell Res       Date:  2018-12-01       Impact factor: 3.905

2.  Deletion of the insulin receptor in the proximal tubule promotes hyperglycemia.

Authors:  Swasti Tiwari; Ravi Shankar Singh; Lijun Li; Susanna Tsukerman; Madan Godbole; Gaurav Pandey; Carolyn M Ecelbarger
Journal:  J Am Soc Nephrol       Date:  2013-05-30       Impact factor: 10.121

3.  MicroRNA-451 inhibits growth of human colorectal carcinoma cells via downregulation of Pi3k/Akt pathway.

Authors:  Hong-Yan Li; Yan Zhang; Jian-Hui Cai; Hong-Lei Bian
Journal:  Asian Pac J Cancer Prev       Date:  2013

4.  miR-192 prevents renal tubulointerstitial fibrosis in diabetic nephropathy by targeting Egr1.

Authors:  F Liu; Z-P Zhang; G-D Xin; L-H Guo; Q Jiang; Z-X Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-07       Impact factor: 3.507

5.  E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta.

Authors:  Bo Wang; Michal Herman-Edelstein; Philip Koh; Wendy Burns; Karin Jandeleit-Dahm; Anna Watson; Moin Saleem; Gregory J Goodall; Stephen M Twigg; Mark E Cooper; Phillip Kantharidis
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

Review 6.  MicroRNAs and their role in progressive kidney diseases.

Authors:  Mitsuo Kato; Laura Arce; Rama Natarajan
Journal:  Clin J Am Soc Nephrol       Date:  2009-07       Impact factor: 8.237

Review 7.  Diabetes complications: the microRNA perspective.

Authors:  Phillip Kantharidis; Bo Wang; Rosemarie M Carew; Hui Yao Lan
Journal:  Diabetes       Date:  2011-07       Impact factor: 9.461

8.  14-3-3 Proteins are Regulators of Autophagy.

Authors:  Mercedes Pozuelo-Rubio
Journal:  Cells       Date:  2012-10-15       Impact factor: 6.600

9.  Urinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats.

Authors:  Aradhana Mohan; Ravi Shankar Singh; Manju Kumari; Devika Garg; Aditya Upadhyay; Carolyn M Ecelbarger; Sucheta Tripathy; Swasti Tiwari
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

Review 10.  The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein-protein interactions.

Authors:  K L Pennington; T Y Chan; M P Torres; J L Andersen
Journal:  Oncogene       Date:  2018-06-18       Impact factor: 9.867

View more
  3 in total

Review 1.  Role of microRNAs in Obesity-Related Kidney Disease.

Authors:  Maite Caus; Àuria Eritja; Milica Bozic
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

Review 2.  To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes Mellitus.

Authors:  Maurice B Fluitt; Neal Mohit; Kanwal K Gambhir; Gail Nunlee-Bland
Journal:  J Diabetes Res       Date:  2022-02-21       Impact factor: 4.011

3.  Mitochondria-Targeted Small Peptide, SS31 Ameliorates Diabetes Induced Mitochondrial Dynamics in Male TallyHO/JngJ Mice.

Authors:  Jasvinder Singh Bhatti; Kavya Thamarai; Ramesh Kandimalla; Maria Manczak; Xiangling Yin; Subodh Kumar; Murali Vijayan; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2020-10-07       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.